Isolation and Characterization of the First Antigen-Specific EGFRvIII vNAR from Freshwater Stingray (<i>Potamotrygon</i> spp.) as a Drug Carrier in Glioblastoma Cancer Cells.

Int J Mol Sci · 2025 · PMC11817625 · PMID 39940647

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The cisplatin-coupled vNAR demonstrated highly significant differences when compared to free CDDP at 72 h.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Isolation and Characterization of the First Antigen-Specific EGFRvIII vNAR from Freshwater Stingray (&lt;i&gt;Potamotrygon&lt;/i&gt; spp.) as a Drug Carrier in Glioblastoma Cancer Cells.

The sentences

Isolation and Characterization of the First Antigen-Specific EGFRvIII vNAR from Freshwater Stingray (<i>Potamotrygon</i> spp.) as a Drug Carrier in Glioblastoma Cancer Cells.